As practising oncologists, we've seen firsthand how a cancer diagnosis changes the way patients engage with information.

Though they are still primarily prescribed for weight loss and diabetes, researchers are looking at the effects of GLP-1s for a wide variety of conditions from substance abuse dis ...

For more than a century, tissue biopsies have stood as the gold standard for diagnosing cancer. And for good reason. These tiny tumour samples can unlock a wealth of molecular information, information ...

Let me start with something most strategy decks dance around: the patent cliff isn't the problem. It's the symptom. Every ...

Women with endometriosis in England could soon be offered simple non-invasive tests for diagnosis of their condition, rather ...

Vertex Pharma has made the largest acquisition in its history, agreeing to buy Crinetics Pharma for around $10 billion in a ...

This month, the European Commission granted centralised marketing authorisation for Zandoriah (teriparatide), a biosimilar to ...

The NHS will include an AI-powered triage tool in the NHS App in an attempt to cut waiting lists and improve care for ...

Roche's Genentech unit has forged an alliance with Astex, worth up to $515 million, to partner on a fragment-based drug ...

Novartis has reached a deal to buy Myricx Bio for up to $1.5 billion, giving it control of the London, UK, start-up's ...

Sir Chris Hoy has said he feels "very proud" when he hears of people taking part in the charity cycling event he set up last ...

Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been recommended for conditional approval in the EU. The EMA's human medicines ...